Amphotericin	amphotericin	O	O
B-induced	b-induced	O	O
seizures	seizures	O	S_disease
in	in	O	O
a	a	O	O
patient	patient	O	O
with	with	O	O
AIDS.OBJECTIVE	aids.objective	O	O
:	:	O	O
To	to	O	O
report	report	O	O
a	a	O	O
case	case	O	O
of	of	O	O
multiple	multiple	O	O
episodes	episodes	O	O
of	of	O	O
seizure	seizure	O	S_disease
activity	activity	O	O
in	in	O	O
an	an	O	O
AIDS	aids	O	S_disease
patent	patent	O	O
following	following	O	O
amphotericin	amphotericin	O	O
B	b	O	O
infusion	infusion	O	O
.	.	O	O

CASE	case	O	O
SUMMARY	summary	O	O
:	:	O	O
A	a	O	O
46-year-old	46-year-old	O	O
African-American	african-american	O	O
man	man	O	O
experienced	experienced	O	O
recurrent	recurrent	O	O
grand	grand	O	B_disease
mal	mal	O	S_disease
seizures	seizures	O	S_disease
during	during	O	O
intravenous	intravenous	O	O
infusion	infusion	O	O
of	of	O	O
amphotericin	amphotericin	O	O
B	b	O	O
,	,	O	O
then	then	O	O
petit	petit	O	B_disease
mal	mal	O	S_disease
seizures	seizures	O	S_disease
as	as	O	O
the	the	O	O
infusion	infusion	O	O
was	was	O	O
stopped	stopped	O	O
and	and	O	O
the	the	O	O
drug	drug	S_chemicals	O
concentrations	concentrations	O	O
decreased	decreased	O	O
with	with	O	O
time	time	O	O
.	.	O	O

The	the	O	O
patients	patients	O	O
concurrent	concurrent	O	O
medications	medications	O	O
included	included	O	O
didanosine	didanosine	S_chemicals	O
,	,	O	O
hydroxyzine	hydroxyzine	S_chemicals	O
,	,	O	O
promethazine	promethazine	S_chemicals	O
,	,	O	O
hydrocortisone	hydrocortisone	S_chemicals	O
,	,	O	O
and	and	O	O
prochlorperazine	prochlorperazine	O	O
.	.	O	O

Despite	despite	O	O
administration	administration	O	O
of	of	O	O
phenytoin	phenytoin	S_chemicals	O
and	and	O	O
lorazepam	lorazepam	O	O
,	,	O	O
the	the	O	O
seizures	seizures	O	S_disease
persisted	persisted	O	O
and	and	O	O
occurred	occurred	O	O
only	only	O	O
during	during	O	O
amphotercin	amphotercin	O	O
B	b	O	O
administration	administration	O	O
.	.	O	O

DISCUSSION	discussion	O	O
:	:	O	O
AIDS	aids	O	S_disease
and	and	O	O
cryptococcal	cryptococcal	O	B_disease
meningitis	meningitis	O	S_disease
,	,	O	O
both	both	O	O
of	of	O	O
which	which	O	O
the	the	O	O
patient	patient	O	O
had	had	O	O
,	,	O	O
can	can	O	O
potentially	potentially	O	O
cause	cause	O	O
seizures	seizures	O	S_disease
.	.	O	O

The	the	O	O
patient	patient	O	O
had	had	O	O
a	a	O	O
history	history	O	O
of	of	O	O
alcohol	alcohol	O	B_disease
abuse	abuse	O	I_disease
;	;	O	O
alcohol	alcohol	O	O
intake	intake	O	O
as	as	O	O
well	well	O	O
as	as	O	O
withdrawal	withdrawal	O	O
can	can	O	O
also	also	O	O
cause	cause	O	O
seizures	seizures	O	S_disease
.	.	O	O

Didanosine	didanosine	S_chemicals	O
also	also	O	O
has	has	O	O
a	a	O	O
potential	potential	O	O
for	for	O	O
inducing	inducing	O	O
seizures	seizures	O	S_disease
.	.	O	O

However	however	O	O
,	,	O	O
these	these	O	O
other	other	O	O
potential	potential	O	O
causes	causes	O	O
of	of	O	O
seizure	seizure	O	S_disease
were	were	O	O
ruled	ruled	O	O
out	out	O	O
.	.	O	O

The	the	O	O
time	time	O	O
course	course	O	O
of	of	O	O
events	events	O	O
suggested	suggested	O	O
that	that	O	O
amphotericin	amphotericin	O	O
B	b	O	O
was	was	O	O
the	the	O	O
cause	cause	O	O
of	of	O	O
the	the	O	O
seizures	seizures	O	S_disease
in	in	O	O
this	this	O	O
AIDS	aids	O	S_disease
patient	patient	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Amphotericin	amphotericin	O	O
B	b	O	O
seems	seems	O	O
to	to	O	O
be	be	O	O
the	the	O	O
probable	probable	O	O
cause	cause	O	O
of	of	O	O
the	the	O	O
seizures	seizures	O	S_disease
.	.	O	O

To	to	O	O
date	date	O	O
,	,	O	O
only	only	O	O
three	three	O	O
cases	cases	O	O
of	of	O	O
seizures	seizures	O	S_disease
associated	associated	O	O
with	with	O	O
amphotericin	amphotericin	O	O
B	b	O	O
have	have	O	O
been	been	O	O
reported	reported	O	O
in	in	O	O
the	the	O	O
literature	literature	O	O
,	,	O	O
but	but	O	O
healthcare	healthcare	O	O
providers	providers	O	O
should	should	O	O
be	be	O	O
aware	aware	O	O
of	of	O	O
the	the	O	O
potential	potential	O	O
for	for	O	O
this	this	O	O
rare	rare	O	O
adverse	adverse	O	O
effect	effect	O	O
.	.	O	O

